ArticleBMJ open2022

What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unit.

Sarah Stapleton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.